HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$9.53
Day range
$9.44 - $9.82
Year range
$5.12 - $17.57
Market cap
742.26M USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 41.37M | 33.95% |
Operating expense | 129.43M | 96.25% |
Net income | -136.06M | -57.60% |
Net profit margin | -328.86 | -17.66% |
Earnings per share | -1.51 | -84.15% |
EBITDA | -129.10M | -42.26% |
Effective tax rate | -0.14% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 441.04M | -21.45% |
Total assets | 663.55M | -17.90% |
Total liabilities | 589.48M | -4.78% |
Total equity | 74.07M | — |
Shares outstanding | 76.13M | — |
Price to book | 9.82 | — |
Return on assets | -47.84% | — |
Return on capital | -64.12% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -136.06M | -57.60% |
Cash from operations | -119.00M | -46.71% |
Cash from investing | 104.90M | 383.21% |
Cash from financing | -525.00K | -100.24% |
Net change in cash | -14.92M | -114.97% |
Free cash flow | -70.35M | 21.25% |
About
Founded
2008
Website
Employees
380